Description

MPEG2Maleimide withsuperiorqualityspecificationof ≥95%Substitution.

MPEG2Maleimidereactswiththiolgroupsoncysteinsidechains,suchasthosepresentontheactiveingredientof Certolizumab-pegol(Cimzia®)[1]. JenKemTechnologyoffersMPEG2Maleimide withMW40000,in1gand10gpackingsizes.DifferentMWofMPEG2Maleimide productsmaybeavailablebycustomsynthesis,pleaseemailus attech@jenkemusa.comfordetailsonmade-to-order PEGs.JenKemTechnology providesrepackagingservicesforanadditionalfee,pleasecontactusifyourequireadifferentpackagesizethanourcatalogselection.

BulkPEGsandGMPgradePEGsaremade-to-order.Pleasecontactusforbulkpricing.

References:

1. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000740/WC500070613.pdf

Foundedin2001byexpertsinPEGsynthesisandPEGylation,JenKemTechnologyspecializesexclusivelyinthedevelopmentandmanufacturingofhighqualitypolyethyleneglycol(PEG)productsandderivatives,andrelatedcustomsynthesisandPEGylationservices.JenKemTechnologyisISO9001andISO13485certified,andadherestoICHQ7AguidelinesforGMPmanufacture.TheproductionofJenKem®PEGsisback-integratedtoin-housepolymerizationdirectlyfromethyleneoxide,enablingfaciletraceABIlityforregulatedcustomers.JenKemTechnologycaterstothePEGylationneedsofthepharmaceutical,biotechnology,medicaldeviceanddiagnostics,andemergingchemicalspecialtymarkets,fromlaboratoryscalethroughlargecommercialscale.

Synonyms: MPEG2LysineMaleimide;MPEG2-LYS-MAL